April 15th, 2025
GC Therapeutics Pioneers Cell Therapy at Warp Speed
With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Harvard Medical School
April 15th, 2025
With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.
February 7th, 2025
The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.
January 24th, 2025
Scientists zoom in on microbial messages at the molecular level to understand how the microbiome shapes health.
September 19th, 2024
GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas.
August 22nd, 2024
Research in mice sheds light on how thyroid hormone alters wiring in the brain.